| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.18e-06 | 194 | 92 | 8 | GO:0016705 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRD GABRP SCN11A SLC46A3 ATP2C1 KCNH8 KCNG1 SLC5A6 SLC28A3 ABCC2 SLC13A2 KCNH3 GABRA2 | 4.31e-05 | 758 | 92 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 8.69e-05 | 19 | 92 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 9.92e-05 | 100 | 92 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | hypoxia-inducible factor-proline dioxygenase activity | 1.25e-04 | 4 | 92 | 2 | GO:0160082 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.37e-04 | 22 | 92 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.92e-04 | 115 | 92 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | transporter activity | GABRD GABRP SCN11A ATG9B SLC46A3 ATP2C1 KCNH8 RHBDF2 KCNG1 SLC5A6 SLC28A3 ATG2A ABCC2 SLC13A2 KCNH3 GABRA2 | 2.47e-04 | 1289 | 92 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRD GABRP SCN11A SLC46A3 ATP2C1 KCNH8 KCNG1 SLC5A6 SLC28A3 SLC13A2 KCNH3 GABRA2 | 2.78e-04 | 793 | 92 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.85e-04 | 28 | 92 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A SLC46A3 ATP2C1 KCNH8 KCNG1 SLC5A6 SLC28A3 SLC13A2 KCNH3 | 2.93e-04 | 465 | 92 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 5.57e-04 | 35 | 92 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | peptidyl-proline 4-dioxygenase activity | 5.77e-04 | 8 | 92 | 2 | GO:0031545 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.03e-03 | 166 | 92 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.17e-03 | 171 | 92 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | peptidyl-proline dioxygenase activity | 1.34e-03 | 12 | 92 | 2 | GO:0031543 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.41e-03 | 48 | 92 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.50e-03 | 49 | 92 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 1.88e-03 | 53 | 92 | 3 | GO:0016879 | |
| GeneOntologyMolecularFunction | glucosidase activity | 2.12e-03 | 15 | 92 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A SLC46A3 ATP2C1 KCNH8 KCNG1 SLC5A6 SLC28A3 SLC13A2 KCNH3 | 2.40e-03 | 627 | 92 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.68e-03 | 60 | 92 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRD GABRP SCN11A SLC46A3 ATP2C1 KCNH8 KCNG1 SLC5A6 SLC28A3 ABCC2 SLC13A2 KCNH3 GABRA2 | 2.88e-03 | 1180 | 92 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 3.06e-03 | 18 | 92 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.36e-03 | 65 | 92 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.36e-03 | 65 | 92 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.36e-03 | 65 | 92 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A SLC46A3 ATP2C1 KCNH8 KCNG1 SLC5A6 SLC28A3 SLC13A2 KCNH3 | 3.51e-03 | 664 | 92 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 3.78e-03 | 20 | 92 | 2 | GO:0031418 | |
| GeneOntologyMolecularFunction | manganese ion binding | 4.31e-03 | 71 | 92 | 3 | GO:0030145 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.48e-03 | 334 | 92 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 4.98e-03 | 239 | 92 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 4.99e-03 | 23 | 92 | 2 | GO:0016881 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.03e-03 | 75 | 92 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | symporter activity | 5.13e-03 | 150 | 92 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.25e-03 | 151 | 92 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.30e-03 | 459 | 92 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.41e-03 | 77 | 92 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 5.49e-03 | 153 | 92 | 4 | GO:0008194 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRD GABRP SCN11A TCAF1 SLC46A3 ATP2C1 ADRB1 KCNH8 KCNG1 SLC5A6 PHB2 SLC28A3 ABCC2 SLC13A2 KCNH3 GABRA2 | 3.10e-05 | 1115 | 92 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRD GABRP SCN11A SLC46A3 ATP2C1 ADRB1 KCNH8 KCNG1 SLC5A6 PHB2 SLC28A3 ABCC2 SLC13A2 KCNH3 GABRA2 | 4.14e-05 | 1017 | 92 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 6.37e-05 | 153 | 92 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.08e-04 | 21 | 92 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.70e-04 | 183 | 92 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRD GABRP SCN11A XIRP1 ADRB1 KCNH8 KCNG1 POPDC3 KCNH3 GABRA2 | 1.94e-04 | 559 | 92 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.07e-04 | 26 | 92 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan biosynthetic process | 2.07e-04 | 26 | 92 | 3 | GO:0050650 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.07e-04 | 26 | 92 | 3 | GO:0006063 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 7.84e-05 | 19 | 93 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.07e-04 | 21 | 93 | 3 | GO:1902710 | |
| Domain | K_chnl_volt-dep_ELK | 6.72e-05 | 3 | 89 | 2 | IPR003950 | |
| Domain | PIM1/2/3 | 6.72e-05 | 3 | 89 | 2 | IPR017348 | |
| Domain | UDPGT | 1.31e-04 | 21 | 89 | 3 | PF00201 | |
| Domain | UDPGT | 1.31e-04 | 21 | 89 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.31e-04 | 21 | 89 | 3 | IPR002213 | |
| Domain | GABAA/Glycine_rcpt | 1.73e-04 | 23 | 89 | 3 | IPR006028 | |
| Domain | cNMP-bd-like | 7.82e-04 | 38 | 89 | 3 | IPR018490 | |
| Domain | PAS_9 | 9.86e-04 | 10 | 89 | 2 | PF13426 | |
| Domain | 2OG-FeII_Oxy_3 | 1.20e-03 | 11 | 89 | 2 | PF13640 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.28e-03 | 45 | 89 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.37e-03 | 46 | 89 | 3 | PF02932 | |
| Domain | Class_I_gatase-like | 1.44e-03 | 12 | 89 | 2 | IPR029062 | |
| Domain | Neur_chan_LBD | 1.46e-03 | 47 | 89 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.46e-03 | 47 | 89 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.46e-03 | 47 | 89 | 3 | IPR006029 | |
| Domain | - | 1.46e-03 | 47 | 89 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 1.46e-03 | 47 | 89 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.46e-03 | 47 | 89 | 3 | IPR006202 | |
| Domain | - | 1.55e-03 | 48 | 89 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 1.85e-03 | 51 | 89 | 3 | IPR014710 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.97e-03 | 14 | 89 | 2 | IPR003938 | |
| Domain | Ion_trans_dom | 2.16e-03 | 114 | 89 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.16e-03 | 114 | 89 | 4 | PF00520 | |
| Domain | P4Hc | 2.58e-03 | 16 | 89 | 2 | SM00702 | |
| Domain | Pro_4_hyd_alph | 2.58e-03 | 16 | 89 | 2 | IPR006620 | |
| Domain | 2OG-FeII_Oxy | 3.64e-03 | 19 | 89 | 2 | PF03171 | |
| Domain | FE2OG_OXY | 4.45e-03 | 21 | 89 | 2 | PS51471 | |
| Domain | PAS_fold_3 | 5.32e-03 | 23 | 89 | 2 | IPR013655 | |
| Domain | PAS_3 | 5.32e-03 | 23 | 89 | 2 | PF08447 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 5.32e-03 | 23 | 89 | 2 | IPR005123 | |
| Domain | PAS-assoc_C | 5.79e-03 | 24 | 89 | 2 | IPR000700 | |
| Domain | PAC | 6.77e-03 | 26 | 89 | 2 | IPR001610 | |
| Domain | PAC | 6.77e-03 | 26 | 89 | 2 | SM00086 | |
| Domain | PAC | 6.77e-03 | 26 | 89 | 2 | PS50113 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 7.73e-07 | 15 | 71 | 4 | MM15697 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.69e-06 | 20 | 71 | 4 | MM14721 | |
| Pathway | REACTOME_DRUG_ADME | 1.77e-05 | 109 | 71 | 6 | M45012 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.91e-05 | 32 | 71 | 4 | MM14719 | |
| Pathway | REACTOME_DRUG_ADME | 2.92e-05 | 119 | 71 | 6 | MM15692 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.89e-05 | 44 | 71 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 7.53e-05 | 45 | 71 | 4 | MM15694 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.19e-04 | 153 | 71 | 6 | MM15844 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.23e-04 | 51 | 71 | 4 | M17726 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.02e-04 | 23 | 71 | 3 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.30e-04 | 24 | 71 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.60e-04 | 25 | 71 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.60e-04 | 25 | 71 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.60e-04 | 25 | 71 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.93e-04 | 26 | 71 | 3 | M39404 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.14e-04 | 183 | 71 | 6 | M39588 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.66e-04 | 28 | 71 | 3 | M19580 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 4.97e-04 | 31 | 71 | 3 | M39369 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 8.80e-04 | 9 | 71 | 2 | M45020 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 9.10e-04 | 38 | 71 | 3 | M39854 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.14e-03 | 41 | 71 | 3 | M7399 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.14e-03 | 41 | 71 | 3 | MM14546 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.31e-03 | 43 | 71 | 3 | M1056 | |
| Pubmed | 2.64e-08 | 66 | 94 | 6 | 19898482 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.91e-08 | 14 | 94 | 4 | 14672974 | |
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 22511988 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 1339448 | ||
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 23642732 | ||
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 11465080 | ||
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.26e-06 | 10 | 94 | 3 | 22558097 | |
| Pubmed | 4.13e-06 | 12 | 94 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 4.13e-06 | 12 | 94 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 5.36e-06 | 13 | 94 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 5.36e-06 | 13 | 94 | 3 | 25246029 | |
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 6.81e-06 | 14 | 94 | 3 | 10836148 | |
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 9295054 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 38400673 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8068691 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 10543731 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24641623 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 31356139 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 17717068 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25081641 | ||
| Pubmed | The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia. | 7.23e-06 | 2 | 94 | 2 | 19737309 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 14627650 | ||
| Pubmed | Kv12-encoded K+ channels drive the day-night switch in the repetitive firing rates of SCN neurons. | 7.23e-06 | 2 | 94 | 2 | 37516908 | |
| Pubmed | Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts. | 7.23e-06 | 2 | 94 | 2 | 26075720 | |
| Pubmed | Presynaptic alpha2-GABAA receptors in primary afferent depolarization and spinal pain control. | 7.23e-06 | 2 | 94 | 2 | 21632935 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 14570768 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 19266083 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.04e-05 | 16 | 94 | 3 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.26e-05 | 17 | 94 | 3 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.80e-05 | 19 | 94 | 3 | 23281178 | |
| Pubmed | Molecular oxygen sensing: implications for visceral surgery. | 2.16e-05 | 3 | 94 | 2 | 22395314 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19965690 | ||
| Pubmed | Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. | 2.16e-05 | 3 | 94 | 2 | 10713710 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23690557 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 32814068 | ||
| Pubmed | The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer. | 2.16e-05 | 3 | 94 | 2 | 36509284 | |
| Pubmed | Characterization and comparative analysis of the EGLN gene family. | 2.16e-05 | 3 | 94 | 2 | 11574160 | |
| Pubmed | Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. | 2.16e-05 | 3 | 94 | 2 | 27561929 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22262480 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 30248340 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 25238262 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28698206 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21887331 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24508125 | ||
| Pubmed | The essential role of PIM kinases in sarcoma growth and bone invasion. | 2.16e-05 | 3 | 94 | 2 | 22623646 | |
| Pubmed | PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation. | 2.16e-05 | 3 | 94 | 2 | 31015445 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28900510 | ||
| Pubmed | Metabolic dysfunction consistent with premature aging results from deletion of Pim kinases. | 2.16e-05 | 3 | 94 | 2 | 24916111 | |
| Pubmed | Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice. | 2.16e-05 | 3 | 94 | 2 | 23360755 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 27502280 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 27981571 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 17069766 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12051676 | ||
| Pubmed | Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. | 2.16e-05 | 3 | 94 | 2 | 22343896 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24195777 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 20959442 | ||
| Pubmed | Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. | 2.16e-05 | 3 | 94 | 2 | 21722213 | |
| Pubmed | PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. | 2.16e-05 | 3 | 94 | 2 | 29781812 | |
| Pubmed | Distribution and functional properties of human KCNH8 (Elk1) potassium channels. | 2.16e-05 | 3 | 94 | 2 | 12890647 | |
| Pubmed | PI3K-like kinases restrain Pim gene expression in endothelial cells. | 2.16e-05 | 3 | 94 | 2 | 22282239 | |
| Pubmed | Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells. | 2.16e-05 | 3 | 94 | 2 | 23495171 | |
| Pubmed | Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene. | 2.16e-05 | 3 | 94 | 2 | 18042805 | |
| Pubmed | Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. | 2.16e-05 | 3 | 94 | 2 | 12234095 | |
| Pubmed | Role of the intracellular localization of HIF-prolyl hydroxylases. | 2.16e-05 | 3 | 94 | 2 | 19339211 | |
| Pubmed | TOP2A, HELLS, ATAD2, and TET3 Are Novel Prognostic Markers in Renal Cell Carcinoma. | 2.16e-05 | 3 | 94 | 2 | 28069330 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 29135068 | ||
| Pubmed | Patterns and Significance of PIM Kinases in Urothelial Carcinoma. | 2.16e-05 | 3 | 94 | 2 | 26551340 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 26774962 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24037093 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 11595184 | ||
| Pubmed | HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. | 2.16e-05 | 3 | 94 | 2 | 11595178 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21877141 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 32504181 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22080570 | ||
| Pubmed | Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates. | 2.16e-05 | 3 | 94 | 2 | 31500697 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 17044072 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24440788 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28418093 | ||
| Pubmed | PIM kinases: an overview in tumors and recent advances in pancreatic cancer. | 2.16e-05 | 3 | 94 | 2 | 24799066 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23209281 | ||
| Pubmed | PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban. | 2.16e-05 | 3 | 94 | 2 | 26075818 | |
| Pubmed | Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. | 2.16e-05 | 3 | 94 | 2 | 22786772 | |
| Pubmed | PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection. | 2.16e-05 | 3 | 94 | 2 | 37797010 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 15199164 | ||
| Pubmed | Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. | 2.16e-05 | 3 | 94 | 2 | 12615973 | |
| Pubmed | Opposing regulation and roles for PHD3 in lung dendritic cells and alveolar macrophages. | 2.16e-05 | 3 | 94 | 2 | 28716863 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18063574 | ||
| Pubmed | PIM kinases as therapeutic targets against advanced melanoma. | 2.16e-05 | 3 | 94 | 2 | 27448973 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22615432 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 33819286 | ||
| Pubmed | Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors. | 2.16e-05 | 3 | 94 | 2 | 20939820 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23611809 | ||
| Pubmed | Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts. | 2.16e-05 | 3 | 94 | 2 | 27614241 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24361227 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21383159 | ||
| Pubmed | HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation. | 2.16e-05 | 3 | 94 | 2 | 37140003 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 20600011 | ||
| Pubmed | 2.45e-05 | 21 | 94 | 3 | 25708312 | ||
| Cytoband | 2q37 | 3.58e-05 | 31 | 94 | 3 | 2q37 | |
| Cytoband | 9q22.2 | 5.53e-04 | 17 | 94 | 2 | 9q22.2 | |
| Cytoband | 3p22.2 | 1.11e-03 | 24 | 94 | 2 | 3p22.2 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 4.72e-05 | 19 | 68 | 3 | 563 | |
| GeneFamily | UDP glucuronosyltransferases | 2.33e-04 | 32 | 68 | 3 | 363 | |
| GeneFamily | Potassium voltage-gated channels | 4.55e-04 | 40 | 68 | 3 | 274 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.23e-03 | 14 | 68 | 2 | 779 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 170 | 93 | 6 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.95e-06 | 177 | 93 | 6 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.22e-06 | 193 | 93 | 6 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-06 | 194 | 93 | 6 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-06 | 194 | 93 | 6 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.32e-06 | 194 | 93 | 6 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.32e-06 | 194 | 93 | 6 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.32e-06 | 194 | 93 | 6 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.32e-06 | 194 | 93 | 6 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.42e-06 | 195 | 93 | 6 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.63e-06 | 197 | 93 | 6 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.73e-06 | 198 | 93 | 6 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | mild-immature_Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.77e-05 | 83 | 93 | 4 | f7225bc24ad6df3a41375cc4614af824e0db3559 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-05 | 169 | 93 | 5 | d59c8cd0719ed0947d42da9e7e5da72ff58ecc0d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.88e-05 | 170 | 93 | 5 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | facs-Heart-RV-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 179 | 93 | 5 | 6aa211670e5d6e013d0980967aa0a4f8f2905efe | |
| ToppCell | facs-Heart-RV-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 179 | 93 | 5 | cf4d3828a3ce97932c68d06f5c65a070fc6d832c | |
| ToppCell | facs-Heart-RV-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 179 | 93 | 5 | f9bc76ff25f88ee44c72499a0df9dc16f519c4cb | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.43e-05 | 186 | 93 | 5 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-05 | 186 | 93 | 5 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 190 | 93 | 5 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 190 | 93 | 5 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 93 | 5 | 5020fe6c3452e7fab57847f5043d28ebbc5aa381 | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 93 | 5 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 192 | 93 | 5 | 24d28e28a5c54ca7770f7e5ad7f4d00039e0aaf9 | |
| ToppCell | (5)_Epi_upper|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.15e-05 | 192 | 93 | 5 | 0c8f73cfd24531a040544df39f28626433aaa651 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_upper|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.15e-05 | 192 | 93 | 5 | 69b6b3ceaad6432c46d1bc2a00b8389069a8876e | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 193 | 93 | 5 | e7805e866339f676e3f770980c2e0a649eff472e | |
| ToppCell | facs-Heart-RA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 193 | 93 | 5 | 1ad941098f1a44a46c2f6ebff32a98ada32c80ab | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.28e-05 | 193 | 93 | 5 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 193 | 93 | 5 | dd443b83d328a9069ffe19ac3d74066e922515a5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 194 | 93 | 5 | 0e9830ad070c47acaa952400bf2a3ddbff664a2f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 194 | 93 | 5 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-05 | 194 | 93 | 5 | 1ac52b00ea0b0ddbd04f5d85fa8c086980a78926 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-05 | 194 | 93 | 5 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | facs-Heart-RA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 195 | 93 | 5 | f4fdcc0b851392086e9618e76ee6a0b540d5fb3c | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 196 | 93 | 5 | ef1482f83872af72a55b6c5b5a1491e6f7f44dd7 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.96e-05 | 198 | 93 | 5 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.10e-05 | 199 | 93 | 5 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-05 | 199 | 93 | 5 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 6.10e-05 | 199 | 93 | 5 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-05 | 200 | 93 | 5 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-05 | 109 | 93 | 4 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-2|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.33e-04 | 124 | 93 | 4 | 9d62f997a1a389386e8d83652bdf109c2a1c96d8 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.59e-04 | 130 | 93 | 4 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.29e-04 | 143 | 93 | 4 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3-Excitatory_Neuron.Slc17a7-Slc17a6.Nxph3-Cbln2-Htr2c_(Deep_layer_subiculum)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.31e-04 | 57 | 93 | 3 | 35494ca30bdafb4c175d74f0b4892098411784b0 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-liver_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.04e-04 | 154 | 93 | 4 | acfbde0fbc09fd69af62a81f8f63e14e36dd1ae0 | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 155 | 93 | 4 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 156 | 93 | 4 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 160 | 93 | 4 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 162 | 93 | 4 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-04 | 163 | 93 | 4 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-04 | 163 | 93 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-04 | 163 | 93 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-04 | 163 | 93 | 4 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-04 | 163 | 93 | 4 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-04 | 163 | 93 | 4 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-04 | 163 | 93 | 4 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-04 | 163 | 93 | 4 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-04 | 165 | 93 | 4 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.04e-04 | 166 | 93 | 4 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, Lineage and Cell Type | 4.13e-04 | 167 | 93 | 4 | 5b7b731944d888591279ef6167b3ae8cab3f6886 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-04 | 167 | 93 | 4 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 167 | 93 | 4 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-04 | 168 | 93 | 4 | c09aa66fd1374ecc4b4d4b56600a6f04aafa5be9 | |
| ToppCell | facs-Heart-RV-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 93 | 4 | 831b000e26b4a7e7fdfa3988372e0281c45eadbb | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.23e-04 | 168 | 93 | 4 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.23e-04 | 168 | 93 | 4 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-04 | 169 | 93 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.52e-04 | 171 | 93 | 4 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-04 | 171 | 93 | 4 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-04 | 171 | 93 | 4 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.62e-04 | 172 | 93 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 173 | 93 | 4 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 173 | 93 | 4 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 173 | 93 | 4 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-04 | 174 | 93 | 4 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-04 | 174 | 93 | 4 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 174 | 93 | 4 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 174 | 93 | 4 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-04 | 174 | 93 | 4 | 0227fea1678baa9168bd47c3b4aacb2592bb5867 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-04 | 174 | 93 | 4 | c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-04 | 174 | 93 | 4 | 84024c04b0ce9f7068677d2d99ede56882b7dbd2 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 175 | 93 | 4 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 175 | 93 | 4 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-04 | 176 | 93 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-04 | 177 | 93 | 4 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 177 | 93 | 4 | c6b955765aee8a196fcf4f7bb16139c95b76dc4e | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-04 | 177 | 93 | 4 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.15e-04 | 177 | 93 | 4 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 177 | 93 | 4 | 2433924dcb085ebbe2545d476ebd7ee68e6092fb | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 178 | 93 | 4 | aa44851653d276226b922ee14dd1fc8d1a844cdf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 178 | 93 | 4 | 462111b61f37338f97ac7dc6c7da1d4316b54445 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 178 | 93 | 4 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 178 | 93 | 4 | ef490b45901b2e6dedb519540fa3ae4e4db3a9ba | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 178 | 93 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| Computational | Neurotransmitter (GABA) receptor. | 6.48e-05 | 15 | 58 | 3 | MODULE_215 | |
| Drug | 4-methylumbelliferyl glucuronide | 4.36e-07 | 38 | 92 | 5 | CID000091553 | |
| Drug | hexobarbital | 8.41e-07 | 127 | 92 | 7 | CID000003608 | |
| Drug | almokalant | 9.24e-07 | 19 | 92 | 4 | CID003033962 | |
| Drug | diosmetin | 1.25e-06 | 85 | 92 | 6 | CID005281612 | |
| Drug | estriol-16-glucuronide | 1.42e-06 | 21 | 92 | 4 | CID000122281 | |
| Drug | campestrol | 1.60e-06 | 49 | 92 | 5 | CID000010134 | |
| Drug | C2-MPAcid | 1.96e-06 | 51 | 92 | 5 | CID000508230 | |
| Drug | Finrazole | 1.96e-06 | 51 | 92 | 5 | CID000178036 | |
| Drug | phenobarbital | UGT1A4 GABRD UGT1A3 GABRP CYP4B1 UGT1A5 PLEC ABCC2 CYP46A1 GABRA2 | 1.97e-06 | 360 | 92 | 10 | CID000004763 |
| Drug | estradiol-3-glucuronide | 2.08e-06 | 23 | 92 | 4 | CID000066651 | |
| Drug | AC1NQGK1 | 2.16e-06 | 52 | 92 | 5 | CID005195977 | |
| Drug | DB04103 | 2.71e-06 | 97 | 92 | 6 | CID004469987 | |
| Drug | SN-38G | 4.07e-06 | 59 | 92 | 5 | CID000443154 | |
| Drug | erucin | 4.75e-06 | 28 | 92 | 4 | CID000078160 | |
| Drug | AC1MRQNQ | 5.27e-06 | 9 | 92 | 3 | CID003522271 | |
| Drug | DHPASiU | 5.27e-06 | 9 | 92 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 5.27e-06 | 9 | 92 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 5.27e-06 | 9 | 92 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 5.27e-06 | 9 | 92 | 3 | CID005460873 | |
| Drug | trans-3'-hydroxycotinine | 5.49e-06 | 29 | 92 | 4 | CID000000414 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 5.54e-06 | 238 | 92 | 8 | CID000001027 | |
| Drug | AC1L9E0Q | 6.31e-06 | 30 | 92 | 4 | CID000443095 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 7.65e-06 | 67 | 92 | 5 | CID000015032 | |
| Drug | AC1Q7AUJ | 8.05e-06 | 117 | 92 | 6 | CID000003303 | |
| Drug | indole-2-carboxylic acid | 8.23e-06 | 32 | 92 | 4 | CID000072899 | |
| Drug | NNAL | 8.23e-06 | 32 | 92 | 4 | CID000104856 | |
| Drug | R(-)-Denopamine | 9.34e-06 | 33 | 92 | 4 | CID000003818 | |
| Drug | 4-nitrophenyl)imidazole | 1.03e-05 | 11 | 92 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 1.03e-05 | 11 | 92 | 3 | CID006442661 | |
| Drug | PhIP-HCl | 1.07e-05 | 123 | 92 | 6 | CID000001530 | |
| Drug | eugenol | 1.17e-05 | 73 | 92 | 5 | CID000003314 | |
| Drug | 2,2,2-trichloroethanol | 1.17e-05 | 73 | 92 | 5 | CID000008259 | |
| Drug | AC1NOWCJ | 1.19e-05 | 35 | 92 | 4 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.19e-05 | 35 | 92 | 4 | CID010436171 | |
| Drug | muraglitazar | 1.33e-05 | 36 | 92 | 4 | CID000206044 | |
| Drug | N-OH-DABZ | 1.37e-05 | 12 | 92 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.37e-05 | 12 | 92 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 1.37e-05 | 12 | 92 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.37e-05 | 12 | 92 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.37e-05 | 12 | 92 | 3 | CID000276709 | |
| Drug | Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.54e-05 | 197 | 92 | 7 | 7415_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.59e-05 | 198 | 92 | 7 | 3944_DN | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A | 1.59e-05 | 198 | 92 | 7 | 4759_DN | |
| Drug | afloqualone | 1.62e-05 | 2 | 92 | 2 | ctd:C033541 | |
| Drug | tritanol | 1.77e-05 | 13 | 92 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.77e-05 | 13 | 92 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.77e-05 | 13 | 92 | 3 | CID000000411 | |
| Drug | metaclazepam | 1.77e-05 | 13 | 92 | 3 | CID000071272 | |
| Drug | harmol | 2.04e-05 | 40 | 92 | 4 | CID000068094 | |
| Drug | phenylbutazone | 2.19e-05 | 83 | 92 | 5 | CID000004781 | |
| Drug | propranolol glucuronide | 2.25e-05 | 14 | 92 | 3 | CID000119515 | |
| Drug | PCB-61 | 2.25e-05 | 14 | 92 | 3 | CID000036401 | |
| Drug | AC1Q6O8B | 2.25e-05 | 41 | 92 | 4 | CID000000334 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.80e-05 | 15 | 92 | 3 | CID000040469 | |
| Drug | afloqualone | 2.80e-05 | 15 | 92 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 2.80e-05 | 15 | 92 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 2.80e-05 | 15 | 92 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 2.80e-05 | 15 | 92 | 3 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 3.44e-05 | 16 | 92 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 3.44e-05 | 16 | 92 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 3.44e-05 | 16 | 92 | 3 | CID005497144 | |
| Drug | thymol | 3.58e-05 | 46 | 92 | 4 | CID000006989 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 4.17e-05 | 17 | 92 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 4.17e-05 | 17 | 92 | 3 | CID000037766 | |
| Drug | dihydroxyaflavinine | 4.17e-05 | 17 | 92 | 3 | CID000156857 | |
| Drug | 1-hydroxypyrene | 4.24e-05 | 48 | 92 | 4 | CID000021387 | |
| Drug | salicylamide | 4.24e-05 | 48 | 92 | 4 | CID000005147 | |
| Drug | AC1L1G0K | 4.60e-05 | 49 | 92 | 4 | CID000003473 | |
| Drug | UDP - Na | 4.75e-05 | 235 | 92 | 7 | CID000001158 | |
| Drug | C11866 | 4.83e-05 | 3 | 92 | 2 | CID000443459 | |
| Drug | AC1LCF1F | 4.92e-05 | 161 | 92 | 6 | CID000627275 | |
| Drug | SureCN12722713 | 4.99e-05 | 18 | 92 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 4.99e-05 | 18 | 92 | 3 | CID000152226 | |
| Drug | Br 2 | 4.99e-05 | 18 | 92 | 3 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 4.99e-05 | 18 | 92 | 3 | CID000036614 | |
| Drug | ApApG | 4.99e-05 | 18 | 92 | 3 | CID003081975 | |
| Drug | C1 11-32 | 4.99e-05 | 18 | 92 | 3 | CID000443077 | |
| Drug | C11131 | 4.99e-05 | 18 | 92 | 3 | CID000443076 | |
| Drug | 9-OH-risperidone | 5.90e-05 | 19 | 92 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 5.90e-05 | 19 | 92 | 3 | CID000091433 | |
| Drug | DEPC | 6.28e-05 | 53 | 92 | 4 | CID000015357 | |
| Drug | HCG 004 | 6.76e-05 | 54 | 92 | 4 | CID000064928 | |
| Drug | tangeretin | 6.76e-05 | 54 | 92 | 4 | CID000068077 | |
| Drug | aminopyrine | 6.87e-05 | 171 | 92 | 6 | CID000006009 | |
| Drug | glucosiduronate | 6.87e-05 | 171 | 92 | 6 | CID000000610 | |
| Drug | tectochrysin | 6.92e-05 | 20 | 92 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 6.92e-05 | 20 | 92 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 6.92e-05 | 20 | 92 | 3 | CID000116545 | |
| Drug | dulcin | 8.06e-05 | 21 | 92 | 3 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 8.06e-05 | 21 | 92 | 3 | CID000069186 | |
| Drug | phenolphthalein | 8.96e-05 | 58 | 92 | 4 | CID000004764 | |
| Drug | amonafide | 9.30e-05 | 22 | 92 | 3 | CID000050515 | |
| Drug | N-methylpiperazine | 9.30e-05 | 22 | 92 | 3 | CID000053167 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 9.40e-05 | 181 | 92 | 6 | 5419_DN | |
| Drug | urochloralic acid | 9.59e-05 | 59 | 92 | 4 | CID003036914 | |
| Drug | acetaminophen glucuronide | 9.59e-05 | 59 | 92 | 4 | CID000083944 | |
| Drug | UDP-alpha-d-xylopyranose | 1.02e-04 | 60 | 92 | 4 | CID000001165 | |
| Drug | 5 beta-pregnanediol | 1.02e-04 | 60 | 92 | 4 | CID000012547 | |
| Drug | amidoxime | 1.07e-04 | 23 | 92 | 3 | CID000465967 | |
| Drug | phenanthridine | 1.07e-04 | 23 | 92 | 3 | CID000009189 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.68e-06 | 8 | 93 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.51e-06 | 9 | 93 | 3 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0020691 | |
| Disease | X-21448 measurement | 3.58e-06 | 10 | 93 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.58e-06 | 10 | 93 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 3.58e-06 | 10 | 93 | 3 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 3.58e-06 | 10 | 93 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 4.91e-06 | 11 | 93 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 4.91e-06 | 11 | 93 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 4.91e-06 | 11 | 93 | 3 | EFO_0800972 | |
| Disease | aldosterone measurement | 4.91e-06 | 11 | 93 | 3 | EFO_0010219 | |
| Disease | biliverdin measurement | 6.53e-06 | 12 | 93 | 3 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 6.53e-06 | 12 | 93 | 3 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 8.47e-06 | 13 | 93 | 3 | EFO_0802007 | |
| Disease | X-21441 measurement | 2.00e-05 | 17 | 93 | 3 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.00e-05 | 17 | 93 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 2.39e-05 | 18 | 93 | 3 | EFO_0801382 | |
| Disease | tissue factor measurement | 3.87e-05 | 21 | 93 | 3 | EFO_0010623 | |
| Disease | Premature aging syndrome | 5.87e-05 | 4 | 93 | 2 | C0231341 | |
| Disease | xanthurenate measurement | 1.04e-04 | 29 | 93 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.16e-04 | 30 | 93 | 3 | EFO_0600017 | |
| Disease | molar-incisor hypomineralization | 3.49e-04 | 9 | 93 | 2 | EFO_0005321 | |
| Disease | pregnenetriol sulfate measurement | 5.31e-04 | 11 | 93 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 5.31e-04 | 11 | 93 | 2 | EFO_0600039 | |
| Disease | pregnenetriol disulfate measurement | 7.49e-04 | 13 | 93 | 2 | EFO_0800587 | |
| Disease | serum metabolite measurement | UGT1A4 UGT1A3 CYP4B1 DNAJC16 UGT1A5 SLC5A6 GBP1 SLC28A3 ABCC2 FMO6P | 7.93e-04 | 945 | 93 | 10 | EFO_0005653 |
| Disease | urate measurement, spine bone mineral density | 8.25e-04 | 58 | 93 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | sleep measurement | 8.93e-04 | 135 | 93 | 4 | EFO_0004870 | |
| Disease | Adrenocortical carcinoma | 1.45e-03 | 18 | 93 | 2 | C0206686 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.09e-03 | 80 | 93 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | thyroxine measurement | 2.32e-03 | 83 | 93 | 3 | EFO_0005130 | |
| Disease | hormone measurement | 2.40e-03 | 84 | 93 | 3 | EFO_0004730 | |
| Disease | cholelithiasis | 2.74e-03 | 88 | 93 | 3 | EFO_0004799 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPVEPLDLAVFWVEF | 451 | P35503 | |
| DPAWLEFLQVIGTFL | 991 | Q14146 | |
| RELVPDRLFVFFNWL | 351 | P08588 | |
| VDIIPGFEFDRWLNT | 471 | Q9H4A4 | |
| FREPLFLDLPKSVDW | 106 | O60911 | |
| PESEWPFLIITDLFL | 211 | Q9UBB4 | |
| FPAVLRWFAERVDLI | 171 | Q9NZN4 | |
| FVEDLGFWRVLLLIF | 186 | Q86W74 | |
| ADVEPIFDRLLFFWS | 176 | Q9H6Z9 | |
| NLRELWSLFDFIFPG | 681 | Q03468 | |
| LFVFWRELRDNVITP | 791 | P98194 | |
| QLFQGFRDLLWLPIE | 1756 | Q2TAZ0 | |
| ETWEERLLRFFSVSP | 191 | Q96D70 | |
| WRTIFLEPETLDLFF | 251 | Q9H2T7 | |
| FDEIILFSLPPALDW | 261 | P43378 | |
| WFLLDVIAALPFDLL | 306 | Q9ULD8 | |
| PIFTLRDLVLWALDE | 1461 | M0R2J8 | |
| EFILLGFSDRPWLEF | 11 | P58173 | |
| LLRLALFVETVDFWG | 86 | Q86WK9 | |
| FQGDFLWPILVVEFL | 26 | Q96G91 | |
| SELWSLLNFLLPDVF | 391 | Q9NRZ9 | |
| SVWRFLRDLELEIPF | 1156 | O00370 | |
| ISPFSLPFWERLLLD | 1396 | Q71F56 | |
| RWSIPTILEFNLFGI | 586 | Q2M2H8 | |
| FFLLLLWLPDTTGEI | 11 | A0A0C4DH55 | |
| FVWELLPTTLLVGFF | 281 | Q96N19 | |
| QFLLFVFLVWDPARL | 11 | P47869 | |
| WRLLGDLLPEAVRFF | 471 | Q9H1B7 | |
| EFILLGFFGRWELQI | 11 | Q8NH43 | |
| RFLELAPDFVGDILW | 146 | P15036 | |
| LTDELAPVFLLRWFY | 501 | Q9Y2G8 | |
| PDFVWTLRDFSLDLE | 176 | P32455 | |
| LDSRFVDKLWLPDTF | 111 | O14764 | |
| SIFFLWRELGPSVLA | 451 | Q92887 | |
| WLFLTDPRLALEVYF | 456 | O60774 | |
| VGWFSLEFLLRLIQA | 276 | Q9UIX4 | |
| GRIAEFFTDLLTWRP | 551 | P0C869 | |
| DTILAEGLHFRIPWF | 61 | Q99623 | |
| WEEFTDPLSFIGRIR | 26 | P29375 | |
| LSRIVELIEPWFIFS | 2096 | Q9P2D7 | |
| TSFLDFLRRCLVWEP | 371 | Q9NR20 | |
| RLLTTFEGKEWILFF | 66 | Q96IV6 | |
| DEPDWESLIFLARLI | 536 | P49915 | |
| PAWGTFRLLEEETLI | 366 | Q9Y6A2 | |
| RLTDFVEFLWDPLST | 561 | P16383 | |
| SRWFICLFVDILPVE | 231 | Q5TC63 | |
| TFLDSLQEFPWVREK | 71 | P78560 | |
| LLWELVTREVPFADL | 381 | Q13418 | |
| FSWLTEEILLRGFDV | 481 | Q6NUI2 | |
| LLFWFRPRALEIIDF | 641 | Q674R7 | |
| IEPKFDRLLFFWSDR | 356 | Q9GZT9 | |
| RVLEFDIGWLAEPIF | 751 | Q9UEF7 | |
| DFFLQWIGRGLLVLE | 116 | P13584 | |
| IPDNVIFREFIWERL | 701 | Q9ULB5 | |
| AIFIIPQGRETEWLF | 301 | Q8N6R0 | |
| PDFFTRVALFRDWID | 226 | P20160 | |
| PDLFLERLAFPDLWL | 486 | O00237 | |
| FVILVLLWFTREPGF | 336 | Q13183 | |
| FPLQFLDSPEWDSLR | 176 | Q9HBV1 | |
| TLDARLVEFLWVPDT | 106 | O00591 | |
| PWILEPSRFFLELNA | 681 | Q5VU65 | |
| LDPSNVIFLRWDFDL | 36 | A6NHM9 | |
| LLDWFERPDSFVLIL | 106 | P11309 | |
| EDLPLFLRCFTVGWI | 651 | Q9Y2M0 | |
| RGVVLRDPTLFSFLW | 466 | Q6PI48 | |
| RDPTLFSFLWVVDFP | 471 | Q6PI48 | |
| FHFWRTPLPEIDLDI | 456 | Q8TF05 | |
| GWVLIDFLLFFIPTL | 196 | Q969N4 | |
| LQEAFGWEPFIRLFT | 836 | Q9Y4C2 | |
| DLIRPWFPEFSEARA | 381 | Q9Y289 | |
| LSWLVRIEPFTTFFL | 2386 | Q8NFP9 | |
| IRELGFEWSFLIIAV | 191 | Q7Z3Q1 | |
| FPRFAARLIFELWQD | 396 | Q8TE99 | |
| LLILRTDPGFIAFDW | 241 | Q9HAS3 | |
| PFEVRLLLLSVWGFL | 936 | Q6P9B9 | |
| LFEPLWHIERTVSFE | 161 | Q7LGC8 | |
| PFILWPISDLFNDLI | 141 | Q8TAZ6 | |
| FLFRDSWEQTLPDGL | 101 | Q8IXP5 | |
| LVEISWFFPSGREDL | 311 | Q8TCY9 | |
| PRSWILPDEFQLFVA | 306 | Q8NHH1 | |
| ADFVLGRDFRPWLIE | 526 | A6PVC2 | |
| DITEDSFSLFWLLEP | 96 | Q9BU61 | |
| SFSLFWLLEPRIEIV | 101 | Q9BU61 | |
| EEQRARDLFFALWIP | 321 | P23921 | |
| FEVPRLVLADSGFWE | 411 | P35590 | |
| LQLLAEWTETFPRDF | 111 | Q8N431 | |
| RPVEPLDLAVFWVEF | 451 | P35504 | |
| RPLFFLTLEADWAEA | 341 | C9JH25 | |
| VIRLLDWFERPDGFL | 106 | Q86V86 | |
| DWFERPDGFLLVLER | 111 | Q86V86 | |
| ERRFPSSFEEIEILW | 441 | Q15149 | |
| EWLRFGFLLPIFIQF | 56 | Q9P2J2 | |
| WPSLLRHRFLEEFIT | 561 | P11388 | |
| RGFILDEFSFLRDPW | 181 | Q9UI33 | |
| LFVELFQSWPLLERP | 731 | Q6PJF5 | |
| TLWLFETKPLDAFRD | 381 | Q702N8 | |
| LLQFWEPLGETRFLV | 731 | Q9H1B5 | |
| RPVEPLDLAVFWVEF | 451 | P22310 | |
| TWFIIDLIAALPFDL | 301 | Q96L42 |